United States v. George Naum, III

UNPUBLISHED
UNITED STATES COURT OF APPEALS
FOR THE FOURTH CIRCUIT
No. 20-4133
UNITED STATES OF AMERICA,
Plaintiff - Appellee,
v.
GEORGE P. NAUM, III,
Defendant - Appellant.
Appeal from the United States District Court for the Northern District of West Virginia, at
Clarksburg. Irene M. Keeley, Senior District Judge. (1:18-cr-00001-IMK-MJA-2)
Submitted: September 10, 2020 Decided: October 13, 2020
Before MOTZ, HARRIS, and QUATTLEBAUM, Circuit Judges.
Affirmed by unpublished per curiam opinion.
Elgine H. McArdle, MCARDLE LAW OFFICES, Wheeling, West Virginia, for Appellant.
William J. Powell, United States Attorney, Wheeling, West Virginia, Sarah E. Wagner,
Assistant United States Attorney, OFFICE OF THE UNITED STATES ATTORNEY,
Clarksburg, West Virginia, for Appellee.
Unpublished opinions are not binding precedent in this circuit.
PER CURIAM:
George P. Naum, III, appeals from his convictions and sentence following his jury
trial. Naum was convicted of conspiracy to distribute suboxone outside the bounds of
professional medical practice between 2008 and 2016, in violation of 21 U.S.C. § 841(a)(1)
and 21 U.S.C. § 846, and four counts of aiding and abetting the distribution of suboxone
outside the bounds of professional medical practice in violation of 21 U.S.C. § 841(a) and
18 U.S.C. § 2. The district court sentenced Naum to six months incarceration followed by
six months of home detention. In addition, the district court imposed a forfeiture order of
$77,063.00. After careful consideration of Naum’s numerous claims on appeal, we affirm.
I.
These charges arose from Naum’s involvement in a Weirton, West Virginia
suboxone clinic known as Advance Healthcare (“Advance”), which was owned and
operated by Sharon Jackson and co-defendant Eric Drake, and which also employed
co-defendant Dr. Felix Brizuela. The evidence at trial viewed in the light most favorable
to the Government was as follows.
Advance was a suboxone clinic that offered its patients office-based addiction
treatment. Jackson, a registered nurse, and Drake, an individual with no medical training,
ran the day-to-day operations of Advance. Advance employed Naum and Brizuela, who
were both authorized to prescribe suboxone to treat drug addiction. Naum and Brizuela
were scheduled to be at Advance just one evening each a week, and when they were not
present, Jackson used their authority pursuant to their “DEA numbers” to issue
prescriptions for suboxone to Advance’s patients.
2
Naum and Brizuela allowed Jackson nearly unfettered use of their DEA numbers,
delegated most of the patient care to Jackson, and frequently missed all or part of their
once-a-week assigned shifts at Advance. In fact, during a two-month period in 2016,
footage from a pole camera placed by investigators outside the clinic revealed that Naum
was present at Advance only 13.9% of the time that it was open to patients and prescriptions
for suboxone were being issued from it. Jackson testified that she could not have treated
patients without the doctors’ DEA numbers.
When they were present in the office, the doctors reviewed and signed off on patient
charts and saw new patients. New patients were given drug screens, filled out paperwork,
met with Jackson, and met with a physician if one were present. If a physician met with
the patient, he told Jackson what beginning dose of suboxone to start the patient on, and
she communicated the prescription to the pharmacy. If no physician was present at the
initial visit, Jackson diagnosed the patient with an opioid use disorder, decided on a daily
dose of suboxone, and called in the prescription using one of the doctors’ DEA numbers
Jackson and Drake both testified that they had verbal agreements with Naum and
Brizuela permitting Jackson to issue prescriptions under their DEA numbers to new
patients who had not seen a physician, so long as she did not prescribe more than 16
milligrams per day. If she conducted the entire initial visit, Jackson scheduled the patient
to come back to see one of the physicians. As a policy, Naum and Brizuela generally only
saw patients on the initial visit or one visit early on in their treatment. Follow-up visits
were generally only with Jackson.
3
In addition to making dosing decisions for new patients who had not been seen by
a physician, Jackson had blanket permission from Naum and Brizuela to wean or decrease
patients’ doses. Naum often wrote instructions in each patient’s medical chart to either
maintain or decrease a patient’s dose, but Jackson had Naum’s permission to disregard
those written instructions based on the conversations she was having with patients. Naum
never confronted Jackson about overriding his written instructions by prescribing different
doses to his patients.
The Government’s expert, Dr. Patrick Marshalek, testified about medical standards
to which physicians who prescribe controlled substances to treat addiction must adhere.
He testified that many of those standards were promulgated by the Substance Abuse and
Mental Health Services Administration (SAMHSA). Marshalek testified that physicians
must maintain an ongoing relationship with patients to whom they prescribe controlled
substances that extends beyond the initial examination and diagnosis. There is a time after
which a doctor-patient relationship expires and must be renewed by another face-to-face
visit in order to continue issuing prescriptions for controlled substances. Marshalek
testified that the rules of the West Virginia Board of Osteopathic Medicine (WVBOM) 1
require physicians to make an in-person examination of patients to whom they are
prescribing controlled substances no less than once every six months for the duration of
their treatment. See W. Va. C.S.R. § 24-1-18.2.a.5.
1
The WVBOM oversees the licensing of osteopathic physicians like Naum and
Brizuela in West Virginia.
4
The WVBOM also prohibits physicians from delegating responsibilities to others
who are not qualified to carry them out. See W. Va. C.S.R. § 24-1-18.1.aa. Marshalek
testified that physicians who prescribe controlled substances to patients may not delegate
their prescriptive authority to others who do not themselves have such authority.
Physicians may not delegate the decision as to dose or medication to a nurse, and they may
not authorize nurses to override their instructions as to dosages or medication. Physicians
must also evaluate patients’ continued need for medication in an ongoing manner. The
prohibition against delegating the responsibility to prescribe suboxone to non-authorized
individuals, including nurses, is expressly explained in the SAMHSA Guidelines.
Marshalek also testified that it is the physician, and not a nurse, who must diagnose a
patient with an opioid use disorder. Marshalek reviewed the charts of the patients who
received the prescriptions charged in the indictment and opined that each prescription was
issued outside the bounds of medicine.
The Government also introduced the testimony of Cpl. J.W. Smith, who in an
undercover capacity, posed as a patient at Advance, as well as various actual patients.
These witnesses testified to either brief examinations by Naum or no examination at all.
Some patients had never met with Naum and/or did not realize he was their doctor. In
addition, there were instances where Jackson weaned the patient where Naum instructed
Jackson to continue the present dose or continued the present dose when Naum instructed
her to wean. On those occasions, Naum signed off on the deviated course after the fact.
5
The court sentenced Naum to a period of six months incarceration followed by six
months of home detention. Although the forfeiture allegation in the indictment was for the
entire amount of Naum’s earnings from Advance during the course of the conspiracy, the
Government at sentencing requested forfeiture of $157,719.52, or 51.9% of Naum’s entire
salary of $303,891.17. The Government’s calculations were based on the percentage of
“illegitimate” 2 prescriptions authorized by Naum’s DEA number for all of Naum’s patients
at the time of the seizure of records, as well as the patients who testified at trial.
The district court concluded that a reasonable calculation of Naum’s criminal
proceeds, based upon a preponderance of the evidence, was $77,063.00. The district court
reached that amount by multiplying Naum’s salary from 2013 to 2016 by 51.9%, the
percentage of illegitimate prescriptions issued by Naum to the 60 patients. In doing so, the
district court sustained Naum’s objection that the trial evidence covered only 2013 through
2016, and not the entire period charged in the indictment as the Government had requested.
II.
Naum sought to testify that he believed 42 C.F.R. § 8.12, entitled “Federal opioid
treatments standards,” applied to his practice of medicine. He asserts that the regulation
was relevant to his “good faith defense.” The district court ruled that this regulation did
not apply to Naum, and thus, any belief that it was applicable was an improper
ignorance-of-the-law defense. On appeal, Naum argues that the district court erred by
2
Prescriptions were considered illegitimate if they were issued without Naum
examining the patient or were issued more than six months after Naum examined the
patient.
6
determining that 42 C.F.R. § 8.12 was not the applicable federal standard for opiate
addiction treatment.
The regulation cited by Naum is contained in a subpart entitled “Certification and
Treatment Standards for Opioid Treatment Programs” (“OTP”). OTPs are defined as
programs or practitioners engaged in opioid treatment that are registered under 21 U.S.C.
§ 823(g)(1). See 42 C.F.R. § 8.2. Naum, however, was registered under the DATA-waiver
provision of 21 U.S.C. § 823(g)(2), 3 and neither he nor Advance was separately registered
under 21 U.S.C. § 823(g)(1). Consequently, neither meets the definition of an OTP.
Naum does not identify specific subparts of § 8.12 that support his purported good
faith defense. However, the text of § 8.12 makes it evident that it applies to OTPs and not
to DATA-waived practitioners like Naum. First, both the terms “OTP” and “practitioner”
are explicitly defined in the regulation, and those definitions are tied to which subpart of
21 U.S.C. § 823(g) an individual or entity is registered under. See 42 C.F.R. § 8.2 (“Opioid
treatment program or ‘OTP’ means a program or practitioner . . . registered under 21 U.S.C.
§ 823(g)(1). . . . Practitioner means a physician . . . who possesses a waiver under 21 U.S.C.
§ 823(g)(2).”). Section 8.12 references, in nearly every provision, the term “opioid
treatment program” or “OTP” and does not include “practitioners.”
Nonetheless, Naum contends that § 8.12 must apply to practitioners as well because
it is the only federal standard that exists for opioid treatment physicians and the federal
Government has pre-empted this area of the law. Naum contends that he was prevented
3
DATA 2000 is an acronym for the Drug Addiction Treatment Act of 2000.
7
from presenting evidence that his conduct was permitted under the applicable federal
regulations. He asserts that “nothing in 42 C.F.R. § 8.12 nor any regulation prohibits a
physician from delegating monitoring compliance with the treatment protocol to a
registered nurse—as Dr. Naum did in this case.” (Appellant’s Br. (ECF No. 15) at 23).
However, contrary to Naum’s argument, the evidence actually showed that Naum
delegated his prescriptive authority, not compliance monitoring. This conduct is squarely
at odds with federal laws and regulations, including those applicable only to OTPs. See 21
U.S.C. § 841(a) (prohibiting distribution of controlled substances “except as authorized”);
21 U.S.C. § 822(b) (permitting certain medical professionals to become authorized); 21
C.F.R. § 1306.04(a) (only a “practitioner” can issue prescriptions); see also United States
v. Joseph, 709 F.3d 1082, 1104 (11th Cir. 2013) (a physician's delivery of a prescription
without conducting any physical examination of the patient provides strong evidence to
support a conviction).
At best, Naum was mistaken about the law. But, as the district court noted, a
mistaken belief about the law is not a defense, not even a defense of good faith. That is
particularly true here where the regulations Naum cited, by their express terms, do not
apply to Naum or his practice. Further, as the government argues, the introduction of
evidence about a regulation that did not apply to Naum or his practice created a reasonable
risk of confusing the jury. See Fed. R. Evid. 403. Accordingly, we conclude that the
district court did not abuse its discretion in prohibiting evidence of federal regulations that
neither applied to Naum nor were relevant to the issues before the jury.
8
III.
Next, Naum contends that the district court abused its discretion in prohibiting him
from presenting evidence that his treatment of patients was for a legitimate medical purpose
and not for some other purpose, such as drug diversion. The Supreme Court held in United
States v. Moore, 423 U.S. 122, 124 (1975), “that registered physicians can be prosecuted
under § 841 when their activities fall outside the usual course of professional practice.”
We have noted that there are no specific guidelines concerning whether a physician acts
outside the usual course of professional practice and that a case-by-case analysis of
evidence is required to determine whether a reasonable inference of guilt may be drawn
from specific facts. United States v. Singh, 54 F.3d 1182, 1187 (4th Cir. 1995). The
Government may meet its burden by establishing that the physician’s actions were not for
legitimate medical purposes in the usual course of professional medical practice or were
beyond the bounds of professional medical practice. Id.; United States v. Tran Trong
Cuong, 18 F.3d 1132, 1141 (4th Cir. 1994). The Government is not required to prove both
prongs (i.e. no legitimate purpose and beyond professional bounds), and therefore, there
was no error in permitting the Government to proceed only on the theory that Naum’s
actions were beyond the bounds of professional medical practice. See Singh, 54 F.3d at
1188 (“In sum, although the testimony does not adduce compelling evidence that Dr. Singh
prescribed with malicious motive or the desire to make a profit, those motivations, though
common in § 841(a)(1) prosecutions, are not required to convict”).
Because the issue of whether Naum’s treatment was for a legitimate medical
purpose was not an element in this case, Naum’s contention that he acted with a legitimate
9
medical purpose was not a viable defense. In fact, there was no dispute at trial that Naum’s
patients suffered from addiction and required treatment. As such, the district court did not
abuse its discretion in prohibiting evidence regarding the medical purposes of Naum’s
treatment.
IV.
Naum next contends that the Government improperly altered the definition of
“outside the usual course of professional practice” such that Naum was convicted of
different crimes than the ones for which he was indicted. A fatal variance—also known as
a constructive amendment—occurs when the Government (through argument or
presentation of the evidence) or the district court (through jury instructions) “broadens the
bases for conviction beyond those charged in the indictment,” effectively amending the
indictment to allow the defendant to be convicted of a crime other than the one charged, in
violation of his Fifth Amendment right to be tried only on the charges made by the grand
jury in the indictment. United States v. Randall, 171 F.3d 195, 203 (4th Cir. 1999). A
constructive amendment is error per se, and it must be corrected on appeal. Id. (citing
United States v. Floresca, 38 F.3d 706, 712-13 (4th Cir. 1994) (en banc)). However,
divergence between the charges and the Government’s proof is not automatically a
constructive amendment or fatal variance; when the facts proven at trial support a finding
that the defendant committed the charged crime, and the allegations in the indictment differ
in some way not essential to that conclusion, a mere non-fatal variance occurs. See United
States v. Miltier, 882 F.3d 81, 93 (4th Cir.), cert. denied, 139 S. Ct. 130 (2018); United
States v. Allmendinger, 706 F.3d 330, 339 (4th Cir. 2013). A variance violates the
10
defendant’s Fifth Amendment rights only if it prejudices him by surprising him at trial and
hindering his defense, “or by exposing him to the danger of a second prosecution for the
same offense.” Allmendinger, 706 F.3d at 339 (internal quotation marks omitted).
Naum was indicted for a conspiracy to “engage in the business of unlawful[l]y,
knowingly, and intentionally distributing and causing to be distributed controlled
substances without a legitimate medical purpose and outside the usual course of
professional practice” and for aiding and abetting the distribution of suboxone “without a
legitimate purpose and outside the usual bounds of professional practice.” (J.A. 35, 41).
First, the district court’s disjunctive instruction (instructing only regarding outside the
course of professional practice and not on legitimate medical purpose) does not broaden
the possible bases for conviction or change the elements of the charged crimes, since (as
discussed above) the applicable law is disjunctive. Thus, even though the indictment
charges in the conjunctive, the court’s disjunctive instruction did not result in a constructive
amendment to the indictment. See United States v. Perry, 560 F.3d 246, 256 (4th Cir.
2009).
Second, the indictment further charges that Naum permitted Jackson to administer
and dispense opioid addiction treatment medications to patients without proper
supervision. The indictment detailed the procedures at Advance, including that Naum did
not regularly see patients and that he signed off on treatment after the fact. Naum does not
allege that these allegations differed from the evidence at trial or that he was not convicted
of distributing suboxone outside the bounds or course of professional practice, as charged.
11
Therefore, Naum was not subjected to a fatal variance, and the district court did not err in
denying his Rule 29 motion for judgment of acquittal.
V.
Naum next asserts that the district court committed plain error in instructing the jury
regarding the definition of “outside the bounds of professional practice.” Specifically, the
district court informed the jury that certain types of evidence can support such a finding,
including prescribing suboxone with only a superficial examination, without an authorized
person taking a medical history, and without a doctor-patient relationship; allowing
unauthorized individuals to diagnose an opioid use disorder or prescribe medication; and
violating an applicable professional regulation. Naum contends that the Government
implied that Naum had violated two provisions of the WVBOM standards: (1) improperly
delegating prescription authority and (2) failing to conduct an in person examination within
six months. Naum then appears to argue that this evidence/argument, combined with the
jury instructions, rendered the violation of WVBOM a strict liability federal offense or
permitted Naum to be found guilty upon only a showing of malpractice.
A jury instruction is not erroneous if, “in light of the whole record, [it] adequately
informed the jury of the controlling legal principles without misleading or confusing the
jury to the prejudice of the objecting party.” Miltier, 882 F.3d at 89. In reviewing a
challenge to the jury instructions, we do not “view a single instruction in isolation,” but
instead “consider whether taken as a whole and in the context of the entire charge, the
instructions accurately and fairly state the controlling law.” United States v. Blankenship,
846 F.3d 663, 670-71 (4th Cir. 2017) (internal quotation marks omitted).
12
We conclude that the district court did not plainly err in instructing the jury. First,
the district court’s initial instructions on the three elements of the offense matched our
description of the offense elements. See United States v. Hurwitz, 459 F.3d 463, 475 (4th
Cir. 2006) (“[T]o convict a doctor for violating § 841, the government must prove: (1) that
the defendant distributed or dispensed a controlled substance; (2) that the defendant acted
knowingly and intentionally; and (3) that the defendant’s actions were not for legitimate
medical purposes in the usual course of his professional medical practice or were beyond
the bounds of medical practice.” (internal quotation marks omitted)); (J.A. 2926-27). The
court’s instruction that the jury must consider the totality of the circumstances in making
its determination that Naum acted outside the scope of professional medical practice was
consistent with this our precedents. See Singh, 54 F.3d at 1187; United States v. Tran Trong
Cuong, 18 F.3d 1132, 1137-38 (4th Cir. 1994); (J.A. 2930) (“[Y]ou should examine all of
his actions and the facts and circumstances in the case.”).
Although Naum faults the district court for giving a list of examples of conduct that
demonstrate a physician acted illegitimately, the court cautioned that its list was
illustrative, not exhaustive. Indeed, the court stated explicitly that the “violation of an
applicable professional regulation alone, however, is not determinative.” (J.A. 2931).
Moreover, the instructions correctly listed factors accepted as relevant by courts on this
issue. See, e.g., Moore, 423 U.S. at 142-43 (giving inadequate physical exam); United
States v. McIver, 470 F.3d 550, 560 (4th Cir. 2006) (violation of professional regulations).
Accordingly, there was no plain error in the jury instructions.
VI.
13
Naum asserts that the forfeiture order was improper because the patient sampling
used was arbitrary and the underlying evidence was not presented to the jury. In addition,
Naum contends that the district court considered certain prescriptions illegitimate even
though they complied with the West Virginia regulations in effect at the time or were
written on a day Jackson consulted with Naum prior to issuing the prescriptions. Finally,
Naum contends that the district court did not properly explain its judgment.
“Criminal forfeiture is part of a defendant’s sentence.” United States v. Martin, 662
F.3d 301, 306 (4th Cir. 2011). Rule 32.2 of the Federal Rules of Criminal Procedure sets
forth the procedure used to effect criminal forfeiture. Id. at 306-07. “After conviction, the
government must establish a nexus between the property for which it is seeking forfeiture
and the crime by a preponderance of the evidence.” Id. at 307. When the Government
seeks a money judgment, the court must determine the amount the defendant will be
ordered to pay, based on evidence already in the record or additional evidence submitted
by the parties and accepted as reliable. Fed. R. Crim. P. 32.2(b)(1)(B).
In this case, the district court entered a forfeiture money judgment of $77,063.20.
This amount constituted 51.9% of the income Naum obtained from Advance from 2013 to
2016. The district court found that Naum’s salary—or at least a portion of it—constituted
proceeds of his crime. The district court also found that taking 51.9% of Naum’s salary
from 2013 to 2016 was “a reasonable approach” because it was “based on not a sampling,
but on a real calculation” of Naum’s prescriptions. (J.A. 3394). The district court explicitly
addressed Naum’s arguments at sentencing and provided appropriate reasoning.
14
Moreover, the district court’s findings regarding the forfeiture money judgment are
supported by reasonable and reliable evidence, and Naum has not demonstrated that those
findings are clearly erroneous or that the court’s ultimate findings were not based on the
preponderance of the evidence. The facts that Naum was occasionally present and
discussed patients with Jackson on the days he was in the office are irrelevant, given that
the determination of illegitimacy of each prescription was based upon Naum not personally
examining the patient. The evidence at trial supported the conclusion that the lack of a
personal examination was relevant and probative as to whether Naum’s actions were
appropriate.
Naum contends that the use of the 60 charts in arriving at the percentage of his
ill-gained proceeds was statistically unsound. However, the basis for the selection of the
60 patient files was well-explained both in the Government’s pre-sentence pleadings and
at the sentencing hearing. Naum’s characterization of the selection of those 60 patient files
as “random” is patently incorrect. The 60 charts were 100% of the patients that Naum was
treating at the time of the DEA seizure and two former patients who were discussed at
length at Naum’s trial. Thus, Naum’s arguments about random sampling are irrelevant.
Finally, Naum complains that certain prescriptions were included in the calculation
which predated the July 1, 2012 enactment of W. Va. C.S.R. § 24-1-18.2.a.5, which
included the requirement that prescriptions must be written within six months of an
examination. While it is correct that there were prescriptions issued prior to July 2012
included in the calculations, the Government alleges that removing both categories of
prescriptions that predated July 2012—the legitimate and the illegitimate—from the
15
calculation would not change the percentage of illegitimate prescriptions. Naum does not
dispute this calculation. Moreover, while the Government chose the six-month
requirement as a touchstone for legitimate/illegitimate prescriptions, such was a
conservative choice, because the state regulations were just one factor in determining the
legitimacy of prescriptions, and the evidence at trial clearly showed that, even when Naum
conducted an examination, it was often perfunctory. In addition, the district court only
included the portion of Naum’s salaries received during an approximately 3-year period,
even though there was no evidence showing that Naum’s actions were any less illegitimate
outside this time period. Because the district court’s forfeiture determination was based on
an application of the law to facts which were well-supported by reasonable and reliable
evidence, we affirm the forfeiture order.
VII.
In his reply brief, Naum raises new claims based on Brizuela’s appeal, which was
decided after Naum filed his opening brief. See United States v. Brizuela, 962 F.3d 784
(4th Cir. 2020) (published, but not argued). The Government responded with a Fed. R.
App. P. 28(j) filing of supplemental authorities addressing Brizuela, and Naum filed a reply
averring that the Government’s filing was an improper sur-reply and should be ignored.
Brizuela was tried on distribution charges unconnected to Naum and Advance. We
reversed Brizuela’s convictions, finding that the testimony of four patients, whose
treatment was not the basis for any charges, was improperly admitted. 962 F.3d at 795-99.
Naum first contends that insufficient evidence supports his conspiracy conviction
because the Government failed to present evidence of prescriptions he wrote prior to 2014.
16
Brizuela held that, in a prosecution for dispensing improper prescriptions, other similar,
but uncharged, criminal behavior was “overkill” or “piling on.” Id. at 796. Brizuela is
irrelevant to Naum’s argument for several reasons. First, Naum was convicted of
conspiracy; Brizuela was not. As such, evidence necessary to “complete the story” of the
underlying crime was necessarily broader. Id. at 794-95. Second, Brizuela did not
challenge the sufficiency of the evidence supporting his conviction, and Brizuela did not
announce any new relevant law. Thus, Naum’s claim could have been raised in his opening
brief. Third, while Brizuela noted that unlawful distribution is charged by citing to a
specific prescription, id. at 795, Naum’s indictment did just this. Naum’s current complaint
that the indictment charged a conspiracy that began in 2008, but did not present evidence
of Naum’s improper prescriptions prior to 2014, is entirely untethered to Brizuela, and the
parties recognized at sentencing that the evidence at trial concerned actions between 2013
and 2016.
Next, Naum asserts that, based on Brizuela, evidence of Brizuela’s and Jackson’s
actions were improperly admitted against Naum on the conspiracy charge. Specifically,
he cites to evidence at his trial that Brizuela examined and prescribed drugs to a patient
who was then transferred to Naum and that Jackson disregarded Naum’s instructions.
Again, Brizuela’s holding is irrelevant to a conspiracy count. Moreover, the “evidence”
Naum cites to was relevant to the charges against him and, actually, beneficial to Naum.
Specifically, the Government presented evidence that Brizuela examined and prescribed
drugs to a patient, subsequently transferred to Naum who continued prescriptions without
ever examining the patient. The evidence that the patient was examined by a licensed
17
professional was not prejudicial to Naum. Further, the evidence that Jackson disregarded
Naum’s instructions came from Naum himself. Jackson, on the other hand, testified that
she had blanket authority to alter Naum’s instructions. Accordingly, Naum’s arguments
based on Brizuela are without merit.
As such, we affirm the district court’s judgment. We dispense with oral argument
because the facts and legal contentions are adequately presented in the materials before this
court and argument would not aid the decisional process.
AFFIRMED
18